David Dean Halbert owns 43.74% of Caris Life Sciences
123,599,535 shares as of the May 15, 2026 filing, worth $3.8B at the latest close.
CAI · $8.6B market cap · Founder-ledGet an email when David Dean Halbert’s stake moves.
Free.
The stake
43.74%
worth $3.8B at the latest close
Stake rank
#35
by dollar value of the stake
Last sale
None
no sales since 2016
Last buy
None
no purchases since 2016
David Dean Halbert owns 43.74% of Caris Life Sciences, Inc.: 123,599,535 of 282,595,186 shares, worth about $3.8B at the 2026-10-16 close. The stake has moved from 6.50% in 2025 to 43.74% on 2026-08-03.
How the stake is held
as of the May 15, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated May 15, 2026 · Form 4 ↗
HELD DIRECTLY
2,574,533
2.1%
HELD INDIRECTLY · Indirect, per the filing’s footnote
121,025,002
97.9%
THE STAKE
123,599,535
43.74%